Lysophosphatidic acid receptor 1 (LPA1) plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia
Abstract Background Lysophosphatidic acid receptor 1 (LPA1) is in the spotlight because its synthetic antagonist has been under clinical trials for lung fibrosis and psoriasis. Targeting LPA1 might also be a therapeutic strategy for cerebral ischemia because LPA1 triggers microglial activation, a co...
Main Authors: | Bhakta Prasad Gaire, Arjun Sapkota, Mi-Ryoung Song, Ji Woong Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-019-1555-8 |
Similar Items
-
Dual Role of Lysophosphatidic Acid Receptor 2 (LPA2) in Amyotrophic Lateral Sclerosis
by: Maria Puigdomenech-Poch, et al.
Published: (2021-03-01) -
NLRP3 Inflammasome Activation Is Involved in LPA<sub>1</sub>-Mediated Brain Injury after Transient Focal Cerebral Ischemia
by: Chi-Ho Lee, et al.
Published: (2020-11-01) -
Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
by: Jie Zhang, et al.
Published: (2020-02-01) -
Identification of genes activated and biological markers involved in lysophosphatidic acid (LPA)-induced breast cancer metastasis through its receptor LPA1
by: Sahay, Debashish
Published: (2015) -
Lysophosphatidic Acid Receptor 5 Plays a Pathogenic Role in Brain Damage after Focal Cerebral Ischemia by Modulating Neuroinflammatory Responses
by: Arjun Sapkota, et al.
Published: (2020-06-01)